TransMedics (TMDX) Net Income towards Common Stockholders Growth (5y) (2023 - 2026)
TransMedics (TMDX) Net Income towards Common Stockholders Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn |
| 2 | Stryker | 127.25 Bn | 123.77 Bn | 4.50 Bn |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.28 Bn | 32.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.64 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn |
| 10 | TransMedics | 3.18 Bn | 2.71 Bn | 113.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.55% |
| Mar 31, 2026 | 23.94% |
| Dec 31, 2025 | 84.76% |
| Sep 30, 2025 | 46.64% |
| Jun 30, 2025 | 43.60% |
| Mar 31, 2025 | 37.42% |
| Dec 31, 2024 | -25.87% |
| Sep 30, 2024 | 20.20% |
| Jun 30, 2024 | 27.17% |
| Mar 31, 2024 | 30.39% |
| Dec 31, 2023 | -34.32% |
| Sep 30, 2023 | -37.86% |
| Jun 30, 2023 | 30.37% |
| Mar 31, 2023 | 11.67% |